Article
E2F1 death pathways as targets for cancer therapy
1 Mar 2007
Abstract excerpt
Defects in apoptotic programs contribute to a number of human diseases, ranging from neurodegenerative disorders to malignancy, and treatment failure. The genetic basis for apoptosis implies that cell death can be disrupted by mutations, raising the intriguing possibility that cell numbers can be regulated by factors that influence cell survival. It is well documented that the E2F1 transcription factor is a key...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
